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Estrogens are neuroprotective factors in several neurological diseases. Neuroglobin
(NGB) is one of the estrogen target genes involved in neuroprotection, but little
is known about its transcriptional regulation. Estrogen genomic pathway in gene
expression regulation is mediated by estrogen receptors (ERα and ERβ) that bind
to specific regulatory genomic regions. We focused our attention on 17β-estradiol
(E2)-induced NGB expression in human differentiated neuronal cell lines (SK-N-BE
and NT-2). Previously, using bioinformatics analysis we identified a putative enhancer
in the first intron of NGB locus. Therefore, we observed that E2 increased the
enrichment of the H3K4me3 epigenetic marks at the promoter and of the H3K4me1
and H3K27Ac at the intron enhancer. In these NGB regulatory regions, we found
estrogen receptor alpha (ERα) binding suggesting that ERα may mediate chromatin
remodeling to induce NGB expression upon E2 treatment. Altogether our data show that
NGB expression is regulated by ERα binding on genomic regulatory regions supporting
hormone therapy applications for the neuroprotection against neurodegenerative
diseases.
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INTRODUCTION
17β-estradiol (E2) has neuroprotective activity in several models of neurodegenerative disorders,
such as multiple sclerosis, ischemia, stroke and Alzheimer’s disease (AD; Arevalo et al., 2015).
E2 genomic signaling is mediated by estrogen receptor alpha (ERα) and beta (ERβ), nuclear
transcription factor receptors bound to regulatory genomic regions, known as promoters and
enhancers. Furthermore, ERs form transcriptional complexes with several transcription factors
and cofactors making long range interactions between promoter and enhancer of target genes
(Welboren et al., 2009). ERs co-regulators contain chromatin remodeler factors, such as histone
modifications enzymes. Chromatin dynamic, linked to epigenetic modifications, is a molecular
mechanism for gene expression activation or repression (Magnani and Lupien, 2014; Heinz et al.,
2015).
Epigenetic changes under E2 control have an impact on memory consolidation and
energy expenditure in hypothalamus (Zhao et al., 2010; Frick et al., 2011; Frank et al., 2014;
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López and Tena-Sempere, 2015). E2 induces an increased
expression of chromatin remodeling enzymes, such as histone
deacetylases, demethylases and acetyltransferases (Zhao et al.,
2010, 2012). In dorsal hippocampus, E2 regulates histone 3
acetylation on the brain-derived neurotrophic factor (BDNF)
promoter (Fortress et al., 2014) and ERα, but not ERβ loss,
induces impaired spatial memory in mice (Bean et al., 2014). In
hypothalamus, E2modulates energy homeostasis through several
pathways, including transcriptional regulation of key genes
in brain metabolism, such as oxytocin receptor, progesterone
receptor (Gagnidze et al., 2013), leptin receptor (Bennett et al.,
1999; Lindell et al., 2001) and pro-opiomelanocortin (Pelletier
et al., 2007).
One target protein that increases upon E2 treatment
is Neuroglobin (NGB), an oxygen-binding protein that acts
as scavenger of reactive oxygen and nitrogen species. NGB
plays a neuroprotective action against oxidative damage, after
stroke injury and in AD models. E2 increases NGB levels in
a dose-dependent manner (1–10 nM). This effect is reached
in 1 h treatment and is maintained for 24 h in human
neuroblastoma cell lines and in mouse primary hippocampal
neurons. The E2 effect on NGB expression is evident also
in primary astrocytes (De Marinis et al., 2011, 2013a).
Neuronal hypoxia and cerebral ischemia increase NGB levels
that protect against neurodegeneration because NGB silencing
induces neuron apoptosis (Greenberg et al., 2008). E2 protects
H2O2-induced apoptosis in neurons (De Marinis et al., 2011).
NGB is overexpressed in early stage of AD and forms a
complex with amyloid-β peptide (Sun et al., 2013; Seal et al.,
2015).
NGB modulation upon E2 treatment is mediated by
ERβ as demonstrated in human neuroblastoma cell line
(SK-N-BE), in mouse primary hippocampal neurons, mouse
astrocytes and several cancer cell lines. ERβ signaling is
mediated by membrane-associated proteins and has an effect
on mitochondria as apoptosis protection (De Marinis et al.,
2011, 2013b; Fiocchetti et al., 2014, 2015). Although these
are well assessed data, the question whether ERα may exert
a direct effect on NGB transcription has not been worked
out in detail, therefore we addressed this question in the
present work using SK-N-BE and NT-2 differentiated cells as
neuronal-like in vitro models. The comparison of two cell
lines from different origin (SK-N-BE, human neuroblastoma
cell lines, and NT-2, human embryonal carcinoma cell line)
upon differentiation conditions represented models to study
E2-induced NGB transcription regulation and find genomic
regulatory regions.
Exploring ENCODE database, we found active histone
marks and several transcription factors binding in the
first intron of NGB locus of different neuronal cell lines
(Cutrupi et al., 2014). Here, we found that E2 induced
ERα binding on NGB locus and remodeled chromatin
by changing epigenetic marks. We demonstrated that an
intronic enhancer, bound by ERα upon E2 treatment, had
active histone marks, suggesting that this intronic enhancer
is an important regulatory region in NGB transcription
regulation. These data showed a potential mechanism by
which E2 may mediate neuroprotective action by NGB against
neurotoxic stimuli opening the way to hormone therapy for
aging.
MATERIALS AND METHODS
Cell Lines and Treatments
SK-N-BE, human neuroblastoma cell line, were maintained
in RPMI (Roswell Park Memorial Institute) 1640 medium
containing 2 mM glutamine and supplemented with 100 mL/L
fetal bovine serum, 10 mL/L non-essential amino acids,
and 10 mL/L antibiotic mixture (penicillin-streptomycin
amphotericin). For differentiation, 2 × 106 were plated in
75 cm2 culture flasks (Corning Costar, Sigma-Aldrich, U.S.A.)
and treated with 10 µM retinoic acid (RA) for 10 days.
NT-2 cells, human embryonal carcinoma cell line,
were maintained in Dulbecco’s modified Eagle’s medium
(DMEM)/F12 (Sigma-Aldrich, U.S.A.), supplemented with 5%
fetal bovine serum and 1% antibiotic mixture comprising
penicillin-streptomycin-amphotericin, in a humidified
atmosphere at 37◦C with 5% CO2. For differentiation,
2 × 106 cells were plated in 75 cm2 culture flasks (Corning
Costar, Sigma-Aldrich, U.S.A.) and exposed to 10 µM RA
for 5 weeks. Growth medium was changed three times
a week. Cells were then replated and, 48 h after, mitotic
inhibitors cytosine arabinoside (1 µM), fluorodeoxyuridine
(10 µM) and uridine (10 µM) were added for 2 weeks
to inhibit the division of non-neuronal cells. Experiments
were performed 4–5 weeks after cessation of RA treatment.
Cells were grown for 24 h in hormone-deprived medium,
obtained from phenol red-free DMEM (31053–028, Life
Technologies, U.S.A) supplemented with 5% charcoal-dextran-
treated serum, and were treated with 17β-estradiol (E2;
E2758–1G, Sigma-Aldrich, U.S.A.) at a final concentration of
10 nM.
Real Time RT-PCR
Total RNA was isolated using the TRIzol reagent (Life
Technologies, U.S.A.). Five hundred nanograms of total RNA
was reverse transcribed using the RETROScript cDNA synthesis
kit (Life Technologies, U.S.A.).
Real-time PCR was performed using 7900HT Fast Real Time
PCR by Applied Biosystems, the iTaqTM Universal SYBRR
Green Supermix (Biorad) a Bio-Rad iQ iCycler detection system
with SYBR green fluorophore. A melting curve analysis was
made after each run to ensure a single amplified product for
every reaction. All reactions were run at least in triplicate
for each sample. Primers to study NGB expression were
as follows NGB-Forward: 5′-TGGAAGACCTGTCCTCACTG-
3′ and NGB-Reverse: 5′-GAGCAGAGACTCACCCACTG-3′
(Zhang et al., 2011). Gene expression was normalized using
specific amplification of 18S.
Immunoblot Analysis
SK-N-BE and NT-2 neuronal cells, treated with the appropriate
experimental conditions, were quickly placed on ice and washed
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with ice-cold PBS. Whole-cell extracts were prepared in ice-cold
lysing buffer Protein concentration in the supernatant was
quantified in triplicate by bicinchoninic acid (BCA) assay. For
determination of NGB, 100 µg of cells lysates were separated
in 15% gels, transferred onto nitrocellulose, and revealed
respectively with antibody anti-NGB (Santa Cruz). Membranes
were stripped and incubated with anti-actin antibody.
Reactions were developed with enhanced chemiluminescence
(ECL) system according with the manufacturer’s protocol
(Amersham-Pharmacia, Biotech, Italia, Cologno Monzese,
Italy). Densitometric analysis was performed by using a software
program (Multi-analyst, version 1.1, Bio-Rad Laboratories,
Segrate, Italy). NGB signal were normalized to those of
corresponding actin, were expressed as arbitrary units of
optical density and were means ± SD of three independent
experiments.
Chromatin Immunoprecipitation Assay
(ChIP)
Differentiated SK-N-BE and NT-2 were treated with vehicle
or E2 and incubated for 45 min and 1 h, after which they
were treated with 1% formaldehyde in PBS for 10 min at room
temperature on a platform shaker. The crosslinking reaction
was stopped by adding glycine at a final concentration of
125 mM. Cells were rinsed twice with cold PBS before harvesting
and crosslinked cells were then resuspended in Cell Lysis
buffer (5 mM Pipes pH 8.0, 85 mM KCl and 0.5% NP-40).
After a 10 min incubation on ice, nuclei were collected by
centrifugation and resuspended in Nuclei Lysis buffer (50 mM
Tris-HCl pH 8.1, 10 mM EDTA and 1% SDS). Cell lysates were
incubated on ice for 10 min and then sonicated 10 times for
20 s at 30% amplitude (SonoPlus HD2070 sonicator). Small
portion of sonicated chromatin (25 µl) was used to verify
that the average size of DNA fragments was in the range
of 250–500 bp. DNA/protein complexes (30 µg) were diluted
in ImmunoPrecipitation buffer (0.01% SDS, 1.1% Triton X-
100, 1.2 mM EDTA, 16.7 mM Tris-HCl pH 8.0 and 167 mM
NaCl) to a final volume of 400 µl. Immunoprecipitations
were performed by adding 1 µg of antibodies against human
ERα H184 and HC20 (Santa Cruz Biotechnology, U.S.A.),
H3K4me3 andH3K4me1 (Diagenode, Belgium), H3K27me3 and
H3K27Ac (Active Motif, U.S.A) and IgG (Abcam, UK) and
then incubating at 4◦C overnight with rotation. Samples with
IgG antibody were run in parallel as negative controls. The
following day, 30 µl of 50% Protein A SepharoseTM 4 Fast
Flow (GE Healthcare, UK) slurry was added and incubated for
2 h at 4◦C to capture the immune complexes. Proteins and
DNA nonspecifically associated with the beads were removed
by sequentially washing with low-salt buffer (0.1% SDS, 1%
Triton X-100, 2 mM EDTA, 20 mM Tris-HCl pH 8.0 and
150 mM NaCl), high-salt buffer (0.1% SDS, 1% Triton X-
100, 2 mM EDTA, 20 mM Tris-HCl, pH 8.0 and 500 mM
NaCl), LiCl washing buffer (0.25 M LiCl; 1% deoxycholate
sodium salt, 1 mM EDTA, 10 mM Tris-HCl pH 8.0 and
1% NP-40) and twice with Tris-EDTA buffer (10 mM Tris-
HCl pH 8.0, 1 mM EDTA) at 4◦C for 5 min each wash.
The immunoprecipitated DNA–protein complexes were eluted
from beads with 1% SDS in 0.1 M NaHCO3. Then the
DNA–protein complexes were incubated with 0.2 M NaCl at
65◦C overnight followed by proteinase K digestion for 1 h at
45◦C to reverse cross-linking. After protein removal, DNA was
purified by phenol/chloroform extraction followed by Et-OH
precipitation.
Quantification of ChIP enriched DNA was performed by
real-time PCR using iTaq Universal SYBR Green Supermix
(Bio-Rad, U.S.A.). The enrichment of target sequences in
the immunoprecipitated samples was normalized on input
samples (1% of total chromatin used per IP) and expressed
as enrichment of specific binding over the control unspecific
IgG binding. Custom ChIP primers are: NGB promoter
forward: 5′-GAGGCGACCAAATTCAACAC-3′, reverse: 5′-
TGCAGAACGTAACTGACATCG-3′; NGB intronic enhancer
forward: 5′-CAGCTTGGATGTAGTGCAGC-3′, reverse: 5′-
TTCAGTTACCCGGTGAGACC-3′; GAPDH (Neg) forward:
5′-TACTAGCGGTTTTACGGGCG-3′, reverse: 5′-TCGAACA
GGAGGAGCAGAGAGCGA-3′.
Bioinformatic Analysis
The FANTOM5 datasets (http://fantom.gsc.riken.jp/5/) contains
transcription start sites (TSSs) and their expression in human
and mouse primary cells, tissues and cell lines using cap
analysis of gene expression (CAGE) (Forrest et al., 2014).
We searched for NGB and analyzed NGB locus using the
Zenbu browser genomic tool (Severin et al., 2014). We
selected the transcripts, enriched in NGB TSS and in the
first intron, expression. For the evaluation of NGB expression
level, the main CAGE peak attributed to the gene (p1@NGB)
was considered. For the evaluation of the expression level
of the RNAs transcribed at the intronic enhancer of NGB,
a window of 100 bp focused on the cluster of CAGE
peak (chr14:77,735,777-7,773,587, hg19 genome assembly) was
selected. The 20 samples associated with the highest CAGE level
were considered.
Statistical Analysis
Statistics were carried out with the GraphPad Prism version 5.03
for Windows by 1-way ANOVA followed by Bonferroni post hoc
test.
RESULTS
NGB Locus in FANTOM5 Database
We previously published bioinformatic analysis on NGB
locus to identify putative regulatory regions. On this
way, we explored a new FANTOM5 database, including
CAGE experiments across over 900 human samples
(Forrest et al., 2014). We found several transcripts in
correspondence of the TSS and in the first intron of NGB
gene (Figure 1). The first intronic transcript maps on the
enhancer that we have previously predicted (chr14:77,735,963-
77,736,462; hg19; Cutrupi et al., 2014). The presence of
the transcripts in an enhancer indicates a site of non-
Frontiers in Cellular Neuroscience | www.frontiersin.org 3 June 2016 | Volume 10 | Article 147
Guglielmotto et al. Neuroglobin Transcription by ERα
FIGURE 1 | Neuroglobin (NGB) locus and transcript expression in FANTOM5 database. Zenbu Genome Browser of human NGB locus (chr14:77,730,
566-77,739,297). In the first three lanes, the transcript annotations from Entrez, Gencode and UCSC database are reported. Sense transcripts are in green and
antisense in purple. The red lane marks the high level of transcription start site (TSS) transcripts. Black arrow indicates antisense transcript in the first intron (chr14:
77,735,803-77,735,866).
coding RNA transcription and these transcripts may
regulate gene expression. Therefore, this region may act as
long distance genomic regulatory region for nearby genes
(Ong and Corces, 2011). However, the expression data on
transcripts stemming from the NGB promoter revealed high
abundance in several brain regions, particularly in the locus
coeruleus, occipital cortex and lobe, amygdala (Figure 2;
NGB promoter CAGE peak). On the contrary, first intronic
transcripts are highly expressed in non-neuronal tissues
identifying this genomic region (Figure 2; NGB intronic
enhancer).
E2 Induces NGB Expression in SK-N-BE
and NT-2 Differentiated Cells
E2-induced NGB protein expression in neuroblastoma cell
lines, SK-N-BE, has been previously demonstrated (De Marinis
et al., 2011) and, here we investigated SK-N-BE and NT-
2 cells upon conditions leading to cell differentiation. Cells
were plated and cultured in full medium, then maintained
in hormone depleted medium for 24 h before being treated
with 10 nM E2 and collected at different time-points (3, 6,
12 and 24 h). Cells grown in hormone depleted medium
and treated 24 h with 10 nM Et-OH vehicle were used for
comparison. By using quantitative RT-PCR we observed that
E2 induced NGB mRNA expression with different kinetic
in the two cell types of cells. SK-N-BE cells showed 4-
fold increase of NGB mRNA after 12 h of E2 treatment
(F(4,15) = 7.7, P < 0.001), and NT-2 cells showed NGB
mRNA level increase (∼6 fold) after 3 h and is maintained
until 12 h (F(4,15) = 44.5, P < 0.0001; Figure 3A). We
analyzed NGB protein level using Western blot: NGB protein
increased 2-fold after 6 h of E2 treatment in SK-N-BE cells
and 3-fold after 3 h in NT-2 cells (Figure 3B). NGB kinetic
activation between mRNA and protein upon E2 treatment is
different suggesting that E2 may regulate NGB by using multiple
mechanisms.
E2 Induces Chromatin Remodeling on NGB
Locus in SK-N-BE and NT2 Differentiated
Cells
One step of transcription regulation for gene expression is
chromatin remodeling. The dynamic changes of epigenetic
modifications are associated with transcription regulation upon
E2 treatment (Métivier et al., 2003). Histone marks define the
specific states of chromatin: histone 3 lysine 4 trimethylation
(H3K4me3) is a marker of active state corresponding to
gene transcription activation in the promoter, histone 3
lysine 27 trimethylation (H3K27me3) is a marker of silenced
state corresponding to gene transcription silencing, whereas
histone 3 lysine 4 monomethylation (H3K4me1) and histone 3
lysine 27 acetylation (H3K27Ac) are markers of active enhancers.
E2 induced the enrichment of H3K27Ac in the active enhancer
(Hah et al., 2013). To address the underlying molecular
mechanisms of how E2 regulates NGB expression we explored
histone modifications at the NGB promoter and intronic
enhancer using chromatin immunoprecipitation followed by
quantitative RT-PCR (ChIP-qPCR). H3K4me3 enrichment was
significantly increased on NGB promoter in both cell types
after 1 h of E2 treatment (F(2,9) = 11.6, P < 0.02 for SK-
N-BE and F(2,9) = 44.1, P < 0.002 for NT-2; Figure 4A).
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FIGURE 2 | NGB main transcript expression in FANTOM5 database. Bar plot reporting the tissues associated with the highest level of transcripts annotated to
the main NGB TSS (p1@NGB) or to the intronic enhancer.
H3K27Ac (F(2,9)= 71.4, P< 0.001 for SK-N-BE and F(2,9)= 22.3,
P < 0.002 for NT-2) and H3K4me1 (F(2,9) = 15.2, P < 0.01
for SK-N-BE and F(2,9) = 62.4, P < 0.001 for NT-2),
increased after 45 min and 1 h of E2 treatment in the
same manner for the two cell types (Figure 4B). Altogether
these data suggest that E2 may regulate NGB transcription by
inducing epigenetic remodeling of NGB promoter and intronic
enhancer.
ERα Binds to NGB Promoter and Intronic
Enhancer upon E2 Treatment in SK-N-BE
and NT-2 Differentiated Cells
E2 induced histone modifications changes and coexpression
of ERα and NGB in different brain regions suggest that E2
may regulate NGB expression by ERα. To verify whether
ERα binds to NGB promoter and putative enhancer
(chr14:77,735,963-77,736,462; hg19; Site B), we performed
ChIP-qPCR experiments in SK-N-BE and NT-2 differentiated
cells using ERα-specific antibodies. E2 induced ERα binding at
NGB promoter and first intron enhancer after 1 h treatment
(Figure 5). GAPDH promoter was used as negative control
for ERα binding. These data suggest that E2-induced ERα
binding on NGB regulatory regions may recruit co-regulators
able to modify chromatin states for NGB transcription
activation.
DISCUSSION
The present study identifies a novel regulatory domain in the
first intron of NGB locus acting as enhancer. E2 induced binding
of ERα and epigenetic modifications in this genomic region in
concert with the promoter. Therefore, we describe ERα-mediated
genomic pathway able to regulate NGB transcription upon E2
treatment.
E2 induces ERα recruitment preferentially to estrogen
response element (ERE) regions. In silico analysis revealed
the absence of a potential ERE in NGB promoter and
intron enhancer. Sp1 and NF-kB transcription factor binding
sites are present on NGB promoter and their binding is
demonstrated in neuroblastoma cell lines (Liu et al., 2012).
Therefore, ERα binding may be mediated by Sp1 and NF-
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FIGURE 3 | NGB mRNA and protein expression in SK-N-BE and NT-2 differentiated neuroblastoma cells. (A) Time-course of NGB mRNA after 10 nM
17β-estradiol (E2) treatment. Error bars are ± SEM of three independent biological replicates: ∗p-value < 0.05, ∗∗p-value < 0.01 and ∗∗∗p-value < 0.001. The
p-values were calculated with one-way analysis of variance (ANOVA) followed by Bonferroni post hoc test. (B) Time-course of NGB protein after 10 nM E2 treatment.
In all cases diagram shows the mean normalized densitometry values.
kB (Welboren et al., 2009). Another transcription factor that
mediates ERα binding is cAMP response element-binding
protein (CREB), bound on mouse NGB promoter in N2a
neuroblastoma cells (Liu et al., 2013). Exploring the ENCODE
database, we found that several transcription factors may
bind the NGB intronic enhancer supporting the hypothesis
that an active transcriptional complex associated with the
intronic enhancer may form an interaction loop with NGB
promoter (Cutrupi et al., 2014). The FANTOM5 database
showed that the first intron transcripts corresponded to
predictive intronic enhancer. CAGE tags identify bidirectional
capped RNAs that are overlapped with active histone marks
for enhancers, H3K27Ac (Andersson et al., 2014). However,
these first intron transcripts are expressed in smooth muscle
where NGB expression is not yet detectable suggesting that
the first intronic enhancer may be in active state in this
specific tissue under basal conditions as a putative alternative
TSS because there is a unidirectional transcript. In neuronal
cells, the first intronic enhancer may shift from poised to
active state after stimuli. In our neuronal models the intronic
enhancer acquires active histone marks upon E2 treatment,
even though there are not any transcripts in these specific cell
types reported in FANTOM5 library. Therefore, the intronic
enhancer may become active after E2 stimulus in neuronal
models.
After gene co-expression analysis based on Allen Brain
Atlas database (ABA), we found that ERα and NGB are
highly co-expressed in hypothalamus (Cutrupi et al., 2014).
Using ABA gene expression profiling analysis across specific
brain regions, steroid hormone receptors co-expression is
associated with cell-types-specific area. In particular, ERα is
highly expressed in the specific regions of hypothalamus in
according with estrogen-regulated genes, such as NGB (Mahfouz
et al., 2016). Estrogen effects in hypothalamic energy homeostasis
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FIGURE 4 | E2 regulates histone modifications in regulatory genomic regions of differentiated SK-N-BE and NT-2 neuroblastoma cells. (A) ChIP-qPCR
analysis of H3K4me3 and H3K27me3 at the promoter of differentiated SK-N-BE and NT-2 cells, treated with 10 nM E2 for 45 min and 1 h. (B) ChIP-qPCR analysis
of H3K4me1 and H3K27Ac at the intronic region differentiated SK-N-BE and NT-2 cells, treated with 10 nM E2 for 45 min and 1 h. Error bars are ± SEM of three
independent biological replicates: ∗p-value < 0.05 and ∗∗p-value < 0.01. The p-values were calculated with 1-way ANOVA followed by Bonferroni post hoc test.
are largely mediated by ERα as demonstrated by ERα and
ERβ knock out models (López and Tena-Sempere, 2015). In
addition, NGB is also expressed in hippocampus in NGB-
overexpressed transgenic mice, under hypoxia and AD (Raida
et al., 2013; Sun et al., 2013) and both ERα and ERβ are
associated with the same pathological conditions (Arevalo et al.,
2015). Altogether these data showed that brain-region-specific
molecular mechanisms may regulate NGB expression upon E2
treatment.
E2 regulates NGB expression through both genomic and
non-genomic pathways as demonstrated in neuronal and non-
neuronal cellular models. E2 enhances NGB protein level in
neuronal cells and induces NGB localization in mitochondria
where, after oxidative stress injury, NGB inhibits pro-apoptotic
signaling by ERβ (De Marinis et al., 2013b). In mouse cortical
astrocytes, ERβ mediates E2-induced NGB expression and in
lipopolysaccharide (LPS)-induced pro-inflammatory signaling
(De Marinis et al., 2013a). In cancer cell lines, ERα is
overexpressed respect to ERβ and mediates NGB expression
upon E2 treatment (Fiocchetti et al., 2014). In this work we used
NT-2 differentiated cells where ERα is over-expressed in respect
to ERβ, therefore ERα contribution to E2-induced chromatin
remodeling at NGB locus may be predominant.
We found that E2 induced ERα binding to NGB promoter
and intron enhancer, correlating with the dynamics of
epigenetic modifications. E2 induced an increased level
of active histone marks H3K4me3 at the NGB promoter
and H3K4me1-H3K27Ac at the intronic enhancer. ERα is
expressed in specific hypothalamus regions that are important
in regulating energy homeostasis (Frank et al., 2014). The
molecular mechanisms that occur in chromatin remodeling
may be an ERα-induced recruitment of co-regulators with
enzymatic activity to induce histone modifications at the
regulatory regions (Green and Carroll, 2007). Several factors
are described to form ERα complexes in breast cancer
models, but little is known in nervous system. SRC-1 and
SRC-2 cofactors, associated with histone acetyltransferase
p300/CBP are expressed in specific hypothalamic neurons
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FIGURE 5 | E2 induces estrogen receptor alpha (ERα) association on
promoter and intron regions of differentiated SK-N-BE and NT-2
neuroblastoma cells. ChIP-qPCR analysis of ERα binding at the promoter,
intronic enhancer (Site B) and negative control region, GAPDH, of
differentiated SK-N-BE (A) and NT-2 (B) cells, treated with 10 nM E2 for
45 min and 1 h. Error bars are ± SEM of three independent biological
replicates.
and regulated progesterone receptor expression isoforms
(Apostolakis et al., 2002; Gagnidze et al., 2013; Acharya et al.,
2015).
In addition, E2 regulated the expression of enzymes
that carry out histone modifications: increased histone
3 acetylation and decreased histone deacetylase, HDAC2
and HDAC3, in hippocampus (Frick, 2015). In memory
consolidation, histone modifications changes are described
on BDNF (Fortress et al., 2014). In this context, E2-
induced memory effects are mediated by non-genomic
pathway where ERK and PI-3 Kinase activated CREB,
which represents the transcription factor driving chromatin
remodeling and regulation of gene expression (Frick,
2015).
In pathological conditions, E2-induced NGB may mediate
an anti-apoptotic response (De Marinis et al., 2011). The
decreased levels of E2 during menopause are associated
with high risk of cognitive impairment, stroke and AD.
E2 has a neuroprotective effect in several animal models
of neurodegenerative diseases, such as ischemia, AD and
experimental autoimmune encephalomyelitis (EAE; Arevalo
et al., 2015). In addition, ERα interaction with neurofibrillary
tangle and NGB-Aβ complexes suggest that proteins
aggregates with ERα and NGB may inhibit their functions,
therefore de-regulation impairs neuroprotective effect in
AD (Sun et al., 2013; Seal et al., 2015; Wang et al., 2016).
NGB is co-expressed with ERα in specific hypothalamic
regions (Hundahl et al., 2008; Cutrupi et al., 2014). NGB
is a heme-protein with oxidative protection function and
forms a complex with cytochrome c in mitochondria (Yu
et al., 2012). E2 regulated energy homeostasis acting on
hypothalamic-specific regions and E2 decline during aging
was associated with body weight increase and fat distribution
(Fontana et al., 2015). Altogether, these data suggest that
E2-induced NGB may regulate mitochondria function:
control of glucose metabolism, ATP generation and neuronal
apoptosis.
NGB is also expressed in hippocampus where ERα functions
is important in memory formation, while ERβ decreased
estrogen-target genes (Han et al., 2013; Cho et al., 2015;
Frick, 2015). ERα knock out and ERα-overexpressed models
demonstrated the central role in the memory function (Foster
et al., 2008; Bean et al., 2014). ERα downregulation was
associated with memory impairment during aging and
menopause period where estrogens decline (Frick, 2015).
Estrogens regulated neurogenesis in hippocampus and play
a central role in neuroplasticity (Barha and Galea, 2010).
Our work points attention on epigenetic modifications
in genomic regulatory regions upon estrogen treatment,
on the same way of epigenetic changes that occur during
aging (Frick et al., 2011). Co-expression of ERα and NGB
in several brain regions suggests that they may regulate
different signaling important for memory formation in the
hippocampus and for energy homeostasis in the hypothalamus.
The data obtained for NT-2 and SK-N-BE differentiated cells
may suggest that transcriptional complex composition and
environment regulate NGB expression upon E2 treatment.
Therefore, these data in the cellular models support the further
experiments in neurodegenerative mice models to investigate
which is the epigenetic context advantageous for hormone
therapy.
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